Initiation and Duration of Systemic Hormone Therapy for Menopausal Symptoms

The authors aimed to investigate the real-world patterns of initiation and continuation of systemic hormone therapy (HT) among women diagnosed with menopause. They found that only 21.7% of eligible women started HT within a year, with significant disparities in initiation and persistence based on age, race, and health conditions. The study highlights critical gaps in menopause management and the need for targeted interventions to improve treatment adherence and equity in care.